Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)

University of Alberta

$12,000.00

Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases

EF 2012-13

Résumé
Several poorly understood diseases that result in failure of the liver are referred to as autoimmune hepatobiliary diseases. These include the bile duct diseases, biliary atresia, primary sclerosing cholangitis and primary biliary cirrhosis as well as autoimmune hepatitis. We do not know what causes these diseases.They are currently thought to occur as a result of an unknown infection or toxin that triggers the disease in a susceptible individual. These autoimmune hepatobiliary diseases account for ~ 25% of all patients undergoing liver transplantation in Canada. Our team has established specialized clinics to study patients with autoimmune hepatobiliary disease in Alberta and we manage nearly all the patients who have had a liver transplant in Alberta as well. Unfortunately, up to a third of patients will develop disease recurrence in the liver transplant suggesting that the triggers that cause the initial disease may still be present in the new liver. Our team has also joined forces with two major international groups who have found some of the genes that may be associated with increased risk of developing the autoimmune liver diseases. We have also found a virus that may be associated with the development of primary biliary cirrhosis and have developed new methods for identifying other infectious agents that may trigger the other autoimmune liver disease. Our goals now are to find the genes, infectious agents and other markers associated with development of autoimmune liver disease. We will then see if we can find these same markers in patients who have had a liver transplant to see if we can predict who may develop recurrent disease. These studies will help us find new ways of managing and hopefully preventing these costly and morbid diseases.
Programme
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
276974
Name
Mason Andrew L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Projecttitle
Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$12,000
Cihrequipment2
$0
Programname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Keyworddelim
Autoimmune Hepatitis; Bioinformatics; Genetics; Genome Wide Association Study; Metabolism; Metabolomics; Metagenomics; Primary Biliary Cirrhosis; Primary Sclerosing Cholangitis; Proteomics
Abstract
Several poorly understood diseases that result in failure of the liver are referred to as autoimmune hepatobiliary diseases. These include the bile duct diseases, biliary atresia, primary sclerosing cholangitis and primary biliary cirrhosis as well as autoimmune hepatitis. We do not know what causes these diseases.They are currently thought to occur as a result of an unknown infection or toxin that triggers the disease in a susceptible individual. These autoimmune hepatobiliary diseases account for ~ 25% of all patients undergoing liver transplantation in Canada. Our team has established specialized clinics to study patients with autoimmune hepatobiliary disease in Alberta and we manage nearly all the patients who have had a liver transplant in Alberta as well. Unfortunately, up to a third of patients will develop disease recurrence in the liver transplant suggesting that the triggers that cause the initial disease may still be present in the new liver. Our team has also joined forces with two major international groups who have found some of the genes that may be associated with increased risk of developing the autoimmune liver diseases. We have also found a virus that may be associated with the development of primary biliary cirrhosis and have developed new methods for identifying other infectious agents that may trigger the other autoimmune liver disease. Our goals now are to find the genes, infectious agents and other markers associated with development of autoimmune liver disease. We will then see if we can find these same markers in patients who have had a liver transplant to see if we can predict who may develop recurrent disease. These studies will help us find new ways of managing and hopefully preventing these costly and morbid diseases.
Competitiondate
201211
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mason, Andrew L; Eksteen, Johannes A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $12,000~ $0~